Search research articles
Contact Us
Filters
Showing results (91-100 of 150) with videos related to
Page
of 15
Sort By:
The International Journal of Artificial Organs
|
May 1, 1982
Regional myocardial blood flow with a nonpulsatile pump
U Losert, W Mohl, D Glogar, et al.
Cardiovascular and Interventional Radiology
|
March 15, 2003
Percutaneous interventions in radiation-associated coronary in-stent restenosis
P Wexberg, G Beran, I Lang, et al.
Thrombosis and Haemostasis
|
August 30, 1985
Prevention of arterial and pulmonary embolism by oral anticoagulants in patients with dilated cardiomyopathy
P A Kyrle, C Korninger, H Gössinger, et al.
European Journal of Radiology
|
February 1, 1989
Cine-MR in dissection of the thoracic aorta
F X Fruehwald, A Neuhold, J Fezoulidis, et al.
Zeitschrift Fur Kardiologie
|
October 1, 1992
[Pimobendan (UDCG 115 BS) in long-term therapy of chronic heart failure]
J Bergler-Klein, S Globits, T Stefenelli, et al.
International Journal of Clinical & Laboratory Research
|
February 24, 2001
Oxidized low-density lipoprotein is localized in the ventricles of hearts from patients with coronary heart disease
C Ekmekcioglu, M R Mehrabi, H D Glogar, et al.
Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology
|
October 24, 2001
The isoprostane 8-epi-PGF(2alpha) is a valuable indicator of oxidative injury in human heart valves
M R Mehrabi, N Serbecic, C Ekmekcioglu, et al.
Coronary Artery Disease
|
May 16, 2001
Adaptive remodeling of the infarct-related artery is associated with recurrent ischemic events after thrombolysis in acute myocardial infarction
M Gyöngyösi, P Wexberg, K Kiss, et al.
The American Journal of Cardiology
|
January 1, 1993
Elevated circulating levels of beta 2-microglobulin in patients with idiopathic dilated cardiomyopathy
G Klappacher, G Mundigler, A Papousek, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
June 24, 2003
Clinical benefit of prostaglandin E1-treatment of patients with ischemic heart disease: stimulation of therapeutic angiogenesis in vital and infarcted myocardium
Mohammad Reza Mehrabi, Nermin Serbecic, Forouzan Tamaddon, et al.
Page
of 15
Search research articles
Search
Showing results (91-100 of 150) with videos related to
Sort By:
Page
of 15
The International Journal of Artificial Organs
|
May 1, 1982
Regional myocardial blood flow with a nonpulsatile pump
U Losert, W Mohl, D Glogar, et al.
Cardiovascular and Interventional Radiology
|
March 15, 2003
Percutaneous interventions in radiation-associated coronary in-stent restenosis
P Wexberg, G Beran, I Lang, et al.
Thrombosis and Haemostasis
|
August 30, 1985
Prevention of arterial and pulmonary embolism by oral anticoagulants in patients with dilated cardiomyopathy
P A Kyrle, C Korninger, H Gössinger, et al.
European Journal of Radiology
|
February 1, 1989
Cine-MR in dissection of the thoracic aorta
F X Fruehwald, A Neuhold, J Fezoulidis, et al.
Zeitschrift Fur Kardiologie
|
October 1, 1992
[Pimobendan (UDCG 115 BS) in long-term therapy of chronic heart failure]
J Bergler-Klein, S Globits, T Stefenelli, et al.
International Journal of Clinical & Laboratory Research
|
February 24, 2001
Oxidized low-density lipoprotein is localized in the ventricles of hearts from patients with coronary heart disease
C Ekmekcioglu, M R Mehrabi, H D Glogar, et al.
Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology
|
October 24, 2001
The isoprostane 8-epi-PGF(2alpha) is a valuable indicator of oxidative injury in human heart valves
M R Mehrabi, N Serbecic, C Ekmekcioglu, et al.
Coronary Artery Disease
|
May 16, 2001
Adaptive remodeling of the infarct-related artery is associated with recurrent ischemic events after thrombolysis in acute myocardial infarction
M Gyöngyösi, P Wexberg, K Kiss, et al.
The American Journal of Cardiology
|
January 1, 1993
Elevated circulating levels of beta 2-microglobulin in patients with idiopathic dilated cardiomyopathy
G Klappacher, G Mundigler, A Papousek, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
June 24, 2003
Clinical benefit of prostaglandin E1-treatment of patients with ischemic heart disease: stimulation of therapeutic angiogenesis in vital and infarcted myocardium
Mohammad Reza Mehrabi, Nermin Serbecic, Forouzan Tamaddon, et al.
Page
of 15